Literature DB >> 3366935

Simple method of estimating severity of pulmonary fibrosis on a numerical scale.

T Ashcroft1, J M Simpson, V Timbrell.   

Abstract

A continuous numerical scale for determining the degree of fibrosis in lung specimens was devised for correlation with other pulmonary variables such as lung function tests or mineral burden. Grading was scored on a scale from 0 to 8, using the average of microscope field scores. The system allows fibrosis to be measured in small samples of tissue (1 cm) which can provide a detailed description of the changes in a lung, currently not possible with most existing methods.

Entities:  

Mesh：

Year:  1988        PMID： 3366935      PMCID： PMC1141479          DOI： 10.1136/jcp.41.4.467

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


  477 in total

1.  The critical early proinflammatory events associated with idiopathic pneumonia syndrome in irradiated murine allogeneic recipients are due to donor T cell infusion and potentiated by cyclophosphamide.

Authors:  A Panoskaltsis-Mortari; P A Taylor; T M Yaeger; O D Wangensteen; P B Bitterman; D H Ingbar; D A Vallera; B R Blazar
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

2.  A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model.

Authors:  J S Swaney; C Chapman; L D Correa; K J Stebbins; R A Bundey; P C Prodanovich; P Fagan; C S Baccei; A M Santini; J H Hutchinson; T J Seiders; T A Parr; P Prasit; J F Evans; D S Lorrain
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

3.  A proteomics approach to identifying key protein targets involved in VEGF inhibitor mediated attenuation of bleomycin-induced pulmonary fibrosis.

Authors:  Yogesh M Kulkarni; Sucharita Dutta; Anand Krishnan V Iyer; Rajkumar Venkatadri; Vivek Kaushik; Vani Ramesh; Clayton A Wright; Oliver John Semmes; Juan S Yakisich; Neelam Azad
Journal:  Proteomics       Date:  2015-11-24       Impact factor: 3.984

4.  Airway Epithelial Telomere Dysfunction Drives Remodeling Similar to Chronic Lung Allograft Dysfunction.

Authors:  Ram P Naikawadi; Gary Green; Kirk D Jones; Natalia Achtar-Zadeh; Julia E Mieleszko; Isabel Arnould; Jasleen Kukreja; John R Greenland; Paul J Wolters
Journal:  Am J Respir Cell Mol Biol       Date:  2020-10       Impact factor: 6.914

5.  Differential effect of soy isoflavones in enhancing high intensity radiotherapy and protecting lung tissue in a pre-clinical model of lung carcinoma.

Authors:  Gilda G Hillman; Vinita Singh-Gupta; David J Hoogstra; Lisa Abernathy; Joseph Rakowski; Christopher K Yunker; Shoshana E Rothstein; Fazlul H Sarkar; Shirish Gadgeel; Andre A Konski; Fulvio Lonardo; Michael C Joiner
Journal:  Radiother Oncol       Date:  2013-09-07       Impact factor: 6.280

6.  MicroRNA-101 attenuates pulmonary fibrosis by inhibiting fibroblast proliferation and activation.

Authors:  Chaoqun Huang; Xiao Xiao; Ye Yang; Amorite Mishra; Yurong Liang; Xiangming Zeng; Xiaoyun Yang; Dao Xu; Michael R Blackburn; Craig A Henke; Lin Liu
Journal:  J Biol Chem       Date:  2017-07-18       Impact factor: 5.157

7.  Preclinical evaluation of human secretoglobin 3A2 in mouse models of lung development and fibrosis.

Authors:  Yan Cai; Melissa E Winn; John K Zehmer; William K Gillette; Jacek T Lubkowski; Aprile L Pilon; Shioko Kimura
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-11-08       Impact factor: 5.464

8.  Nitric oxide mediates bleomycin-induced angiogenesis and pulmonary fibrosis via regulation of VEGF.

Authors:  Anand Krishnan V Iyer; Vani Ramesh; Carlos A Castro; Vivek Kaushik; Yogesh M Kulkarni; Clayton A Wright; Rajkumar Venkatadri; Yon Rojanasakul; Neelam Azad
Journal:  J Cell Biochem       Date:  2015-11       Impact factor: 4.429

9.  Small airways pathology in idiopathic pulmonary fibrosis: a retrospective cohort study.

Authors:  Stijn E Verleden; Naoya Tanabe; John E McDonough; Dragoş M Vasilescu; Feng Xu; Wim A Wuyts; Davide Piloni; Laurens De Sadeleer; Stijn Willems; Cindy Mai; Jeroen Hostens; Joel D Cooper; Erik K Verbeken; Johny Verschakelen; Craig J Galban; Dirk E Van Raemdonck; Thomas V Colby; Marc Decramer; Geert M Verleden; Naftali Kaminski; Tillie-Louise Hackett; Bart M Vanaudenaerde; James C Hogg
Journal:  Lancet Respir Med       Date:  2020-02-13       Impact factor: 30.700

10.  Mesenchymal Stem Cell Therapy Protects Lungs from Radiation-Induced Endothelial Cell Loss by Restoring Superoxide Dismutase 1 Expression.

Authors:  Diana Klein; Jennifer Steens; Alina Wiesemann; Florian Schulz; Farnusch Kaschani; Katharina Röck; Masahiro Yamaguchi; Florian Wirsdörfer; Markus Kaiser; Jens W Fischer; Martin Stuschke; Verena Jendrossek
Journal:  Antioxid Redox Signal       Date:  2016-11-14       Impact factor: 8.401
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.